International Conference on Neurodegenerative Disorders and Molecular Pathways

This track will explore the intricate molecular pathways that contribute to neurodegenerative disorders. Emphasis will be placed on understanding the biochemical processes leading to neuronal death and dysfunction.

This session will focus on the role of protein aggregation in neurodegenerative diseases, examining how misfolded proteins contribute to neuronal toxicity. Discussions will include potential therapeutic strategies targeting protein aggregation.

This track will investigate the impact of neuroinflammation on the progression of neurodegenerative disorders. Research on inflammatory pathways and their modulation will be highlighted as potential therapeutic avenues.

This session will address the mechanisms underlying synaptic dysfunction in various neurodegenerative conditions. Insights into synaptic plasticity and its implications for neuronal communication will be discussed.

This track will delve into the genetic factors influencing neurodegenerative disorders, focusing on the role of genetic mutations and polymorphisms. The session aims to bridge the gap between genetics and molecular pathology.

This session will explore the cellular signaling pathways implicated in neurodegenerative diseases. Understanding these pathways is crucial for identifying molecular targets for therapeutic intervention.

This track will examine the role of oxidative stress in neuronal injury and death associated with neurodegeneration. Research on antioxidant strategies and their efficacy in promoting neuronal survival will be presented.

This session will focus on the identification and validation of biomarkers for early diagnosis and monitoring of neurodegenerative diseases. Emphasis will be placed on the translational potential of these biomarkers in clinical settings.

This track will highlight innovative therapeutic strategies aimed at mitigating the effects of neurodegenerative disorders. Discussions will include pharmacological and non-pharmacological interventions.

This session will explore various models used to study neurodegenerative disorders, including in vitro, in vivo, and computational approaches. The relevance of these models in understanding disease mechanisms and testing therapies will be discussed.

This track will focus on the molecular neurobiology underlying various brain disorders, including neurodegenerative diseases. Research on cellular and molecular targets for intervention will be a key theme.